Search This Blog

Sunday, November 8, 2015

Amgen Presents Detailed Data Comparing Etelcalcetide With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

Phase 3 Results Presented at ASN Kidney Week 2015 Highlight Potential of Novel Intravenous Calcimimetic Treatment Option



Amgen - Investors - RSS Content

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.